NCT05588128View on ClinicalTrials.gov

Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL

RecruitingOBSERVATIONAL

Enrollment

350

Participants

Timeline

Start Date

March 21, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Prostate CancerBiochemically Recurrent

Interventions

DRUG

18F-DCFpyL

Administered to Cohort.

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH